litlas
Log inCreate account

Christopher H. Crane

Active 1999–2025

Also published as
Christopher H Crane
151
Papers
25,705
Citations
88
h-index
144
i10-index

Citations

Citations per year for Christopher H. Crane1922: 1 citations1986: 1 citations1992: 1 citations1995: 1 citations2001: 3 citations2002: 16 citations2003: 11 citations2004: 28 citations2005: 56 citations2006: 60 citations2007: 83 citations2008: 86 citations2009: 130 citations2010: 155 citations2011: 139 citations2012: 186 citations2013: 200 citations2014: 165 citations2015: 181 citations2016: 183 citations2017: 193 citations2018: 176 citations2019: 719 citations2020: 972 citations2021: 770 citations2022: 627 citations2023: 543 citations2024: 808 citations2025: 375 citations2026: 6 citations1923–1985: no citations, so these years are not shown1987–1991: no citations, so these years are not shown1993–1994: no citations, so these years are not shown1996–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,186 citing papers, 28.6% of this breakdownChina: 812 citing papers, 10.6% of this breakdownItaly: 464 citing papers, 6.1% of this breakdownGermany: 411 citing papers, 5.4% of this breakdownUnited Kingdom: 398 citing papers, 5.2% of this breakdownJapan: 344 citing papers, 4.5% of this breakdownNetherlands: 313 citing papers, 4.1% of this breakdownFrance: 287 citing papers, 3.7% of this breakdownCanada: 243 citing papers, 3.2% of this breakdownSouth Korea: 229 citing papers, 3% of this breakdownSpain: 187 citing papers, 2.4% of this breakdownAustralia: 176 citing papers, 2.3% of this breakdown
0%28.6%Other 20.9%

Institutions

Fields

  • Medicine86.1%
  • Biochemistry, Genetics and Molecular Biology7.7%
  • Physics and Astronomy2.5%
  • Immunology and Microbiology1.3%
  • Engineering0.6%
  • Computer Science0.6%
  • Other1.2%

Topics

  • Pancreatic and Hepatic Oncology Research12.5%
  • Cholangiocarcinoma and Gallbladder Cancer Studies6.9%
  • Colorectal Cancer Surgical Treatments5.7%
  • Colorectal and Anal Carcinomas5%
  • Cancer Immunotherapy and Biomarkers3.5%
  • Pancreatitis Pathology and Treatment3%
  • Other63.4%

Coauthors

All papers

Open in search
  1. PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

    Authors: Andrea Cercek, Melissa Lumish, Jenna Sinopoli, Jill Weiss, Jinru Shia, Michelle F. Lamendola-Essel, Imane H. El Dika, Neil H. Segal, Marina Shcherba, Ryan Sugarman, Zsofia K. Stadler, Rona Yaeger, J. Joshua Smith, Benoı̂t Rousseau, Guillem Argilés, Mitesh Patel, Avni M. Desai, Leonard B. Saltz, Maria Widmar, Krishna Iyer, Janie Y. Zhang, Nicole Gianino, Christopher H. Crane, Paul B. Romesser, Emmanouil P. Pappou, Philip Paty, Julio García‐Aguilar, Mithat Gönen, Marc J. Gollub, Martin R. Weiser, Kurt A. Schalper, Luis A. Díaz - New England Journal of Medicine 2022 cited by 1,542

  2. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

    Authors: J. Joshua Smith, Paul Strombom, Oliver S. Chow, Campbell S.D. Roxburgh, Patricio B. Lynn, Anne Eaton, Maria Widmar, Karuna Ganesh, Rona Yaeger, Andrea Cercek, Martin R. Weiser, Garrett M. Nash, José G. Guillem, Larissa K. Temple, Sree B. Chalasani, James L. Fuqua, Iva Petkovska, Abraham J. Wu, Marsha Reyngold, Efsevia Vakiani, Jinru Shia, Neil H. Segal, James D. Smith, Christopher H. Crane, Marc J. Gollub, Mithat Gönen, Leonard B. Saltz, Julio García‐Aguilar, Philip B. Paty - JAMA Oncology 2019 cited by 594

  3. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    Authors: Andrea Cercek, Campbell S.D. Roxburgh, Paul Strombom, J. Joshua Smith, Larissa K. Temple, Garrett M. Nash, José G. Guillem, Philip B. Paty, Rona Yaeger, Zsofia K. Stadler, Kenneth Seier, Mithat Gönen, Neil H. Segal, Diane Reidy‐Lagunes, Anna M. Varghese, Jinru Shia, Efsevia Vakiani, Abraham J. Wu, Christopher H. Crane, Marc J. Gollub, Julio García‐Aguilar, Leonard B. Saltz, Martin R. Weiser - JAMA Oncology 2018 cited by 645

  4. Metastatic Pancreatic Cancer: ASCO Guideline Update

    Authors: Davendra Sohal, Erin B. Kennedy, Pelin Cinar, Thierry Conroy, Mehmet Sitki Copur, Christopher H. Crane, Ignacio Garrido‐Laguna, Michelle Lau, Tyler Johnson, Smitha Krishnamurthi, Cassadie Moravek, Eileen M. O’Reilly, Philip A. Philip, Shubham Pant, Manish A. Shah, Vaibhav Sahai, Hope E. Uronis, Neeha Zaidi, Daniel A. Laheru - Journal of Clinical Oncology 2020 cited by 289

  5. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

    Authors: Rachna T. Shroff, Erin B. Kennedy, Melinda Bachini, Tanios Bekaii‐Saab, Christopher H. Crane, Julien Edeline, Anthony B. El-Khoueiry, Mary Feng, Matthew H. G. Katz, John Primrose, Heloisa P. Soares, Juan W. Valle, Shishir K. Maithel - Journal of Clinical Oncology 2019 cited by 450

  6. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

    Authors: Gauri R. Varadhachary, Eric P. Tamm, James L. Abbruzzese, Henry Q. Xiong, Christopher H. Crane, Huamin Wang, Jeffrey E. Lee, Peter W. T. Pisters, Douglas B. Evans, Robert A. Wolff - Annals of Surgical Oncology 2006 cited by 874

  7. Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

    Authors: Chaitanya Churi, Rachna T. Shroff, Ying Wang, Asif Rashid, Hyunseon C. Kang, J. Weatherly, Mingxin Zuo, Ralph Zinner, David S. Hong, Funda Meric‐Bernstam, Filip Jankú, Christopher H. Crane, Lopa Mishra, J.N. Vauthey, Robert A. Wolff, Gordon B. Mills, Milind Javle - PLoS ONE 2014 cited by 454

  8. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

    Authors: Patrick J. Loehrer, Yang Feng, Higinia R. Cárdenes, Lynne I. Wagner, Joanna M. Brell, David Cella, Patrick J. Flynn, Ramesh K. Ramanathan, Christopher H. Crane, Steven R. Alberts, Al B. Benson - Journal of Clinical Oncology 2011 cited by 832

  9. Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

    Authors: Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans, Charlotte C. Sun, Jeffrey E. Lee, Jason B. Fleming, Nicolas J. Vauthey, Eddie K. Abdalla, Christopher H. Crane, Robert A. Wolff, Gauri R. Varadhachary, Rosa F. Hwang - Journal of the American College of Surgeons 2008 cited by 820

  10. Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial

    Authors: Howard P Safran, Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo, Michael G Haddock, Theodore S Hong, Lawrence P Leichman, Lakshmi Rajdev, Murray Resnick, Lisa A Kachnic, Samantha Seaward, Harvey Mamon, Dayssy Alexandra Diaz Pardo, Carryn M Anderson, Xinglei Shen, Anand K Sharma, Alan W Katz, Jonathan Salo, Kara L Leonard, Jennifer Moughan, Christopher H Crane - The Lancet Oncology 2022 cited by 103

  11. Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer

    Authors: Neil H. Segal, Andrea Cercek, Geoffrey Y. Ku, Abraham J. Wu, Andreas Rimner, Danny N. Khalil, Diane Reidy‐Lagunes, John Cuaron, Jonathan T. Yang, Martin R. Weiser, Paul B. Romesser, Zsofia K. Stadler, Anna M. Varghese, Karuna Ganesh, Rona Yaeger, Louise C. Connell, David M. Faleck, Ghassan K. Abou‐Alfa, Kathleen C. Mcauliffe, Pamela Vaiskauskas, Mark L. Solter, Martinique Ogle, Matthew Adamow, Aliya Holland, Pallavi Vedantam, Phillip Wong, Taha Merghoub, Efsevia Vakiani, Travis J. Hollmann, Krishna Juluru, Joanne F. Chou, Marinela Capanu, Joseph P. Erinjeri, Stephen B. Solomon, Yoshiya Yamada, Nancy E. Kemeny, Christopher H. Crane, Leonard B. Saltz - Clinical Cancer Research 2021 cited by 86

  12. Hilar Cholangiocarcinoma: expert consensus statement

    Authors: John C. Mansour, Thomas A. Aloia, Christopher H. Crane, Julie K. Heimbach, Masato Nagino, Jean‐Nicolas Vauthey - HPB 2015 cited by 415

  13. Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    Authors: Edward P. Balaban, Pamela B. Mangu, Alok A. Khorana, Manish A. Shah, Somnath Mukherjee, Christopher H. Crane, Milind Javle, Jennifer R. Eads, Peter J. Allen, Andrew H. Ko, Anitra Engebretson, Joseph M. Herman, John H. Strickler, Al B. Benson, Susan G. Urba, Nelson S. Yee - Journal of Clinical Oncology 2016 cited by 378

  14. Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer

    Authors: Marsha Reyngold, Eileen M. O’Reilly, Anna M. Varghese, Megan Fiasconaro, Melissa Zinovoy, Paul B. Romesser, Abraham J. Wu, Carla Hajj, John Cuaron, Richard Tuli, Lara Hilal, Danny N. Khalil, Wungki Park, Ellen Yorke, Zhigang Zhang, Kenneth H. Yu, Christopher H. Crane - JAMA Oncology 2021 cited by 185

  15. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

    Authors: Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale, Gauri Varadhachary, Jeffrey E. Lee, Robert A. Wolff, Huamin Wang, James L. Abbruzzese, Peter W. T. Pisters, Jean‐Nicolas Vauthey, Chusilp Charnsangavej, Eric P. Tamm, Christopher H. Crane, Aparna Balachandran - Cancer 2012 cited by 527

  16. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

    Authors: Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap, Edgar Ben‐Josef, Erin McDonnell, Lawrence S. Blaszkowsky, Eunice L. Kwak, Jill N. Allen, Jeffrey W. Clark, Lipika Goyal, Janet E. Murphy, Milind Javle, John A. Wolfgang, Lorraine C. Drapek, Ronald S. Arellano, Harvey J. Mamon, John T. Mullen, Sam S. Yoon, Kenneth K. Tanabe, Cristina R. Ferrone, David P. Ryan, Thomas F. DeLaney, Christopher H. Crane, Andrew X. Zhu - Journal of Clinical Oncology 2015 cited by 470

  17. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis

    Authors: Randa Tao, Sunil Krishnan, Priya Bhosale, Milind Javle, Thomas A. Aloia, Rachna T. Shroff, Ahmed O. Kaseb, Andrew J. Bishop, Cameron W. Swanick, Eugene J. Koay, Howard D. Thames, Theodore S. Hong, Prajnan Das, Christopher H. Crane - Journal of Clinical Oncology 2015 cited by 308

  18. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta‐analysis

    Authors: Leila T. Tchelebi, Eric J. Lehrer, Daniel M. Trifiletti, Navesh Sharma, Niraj J. Gusani, Christopher H. Crane, Nicholas G. Zaorsky - Cancer 2020 cited by 123

  19. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer

    Authors: Jillian R. Gunther, Awalpreet S. Chadha, Sushovan Guha, Gottumukkala S. Raju, Dipen M. Maru, Mark F. Munsell, Yan Jiang, Peiying Yang, Edd Felix, M. Clemons, Geena George Mathew, Pankaj K. Singh, John M. Skibber, Miguel A. Rodrı́guez-Bigas, George J. Chang, Cathy Eng, Marc E. Delclos, Christopher H. Crane, Prajnan Das, Sunil Krishnan - Journal of Gastrointestinal Oncology 2022 cited by 31

  20. Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation

    Authors: Sunil Krishnan, Awalpreet S. Chadha, Yelin Suh, Hsiang-Chun Chen, Arvind Rao, Prajnan Das, Bruce D. Minsky, Usama Mahmood, Marc E. Delclos, Gabriel O. Sawakuchi, Sam Beddar, Matthew H. G. Katz, Jason B. Fleming, Milind Javle, Gauri R. Varadhachary, Robert A. Wolff, Christopher H. Crane - International Journal of Radiation Oncology*Biology*Physics 2015 cited by 369

  21. Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

    Authors: Deyali Chatterjee, Matthew H. G. Katz, Asif Rashid, Hua Wang, Alina C. Iuga, Gauri R. Varadhachary, Robert A. Wolff, Jeffrey E. Lee, Peter W. T. Pisters, Christopher H. Crane, Henry F. Gomez, James L. Abbruzzese, Jason B. Fleming, Huamin Wang - The American Journal of Surgical Pathology 2012 cited by 207

  22. Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer

    Authors: Mohan Suntharalingam, Kathryn Winter, David H. Ilson, Adam P. Dicker, Lisa A. Kachnic, André Konski, A. Bapsi Chakravarthy, Christopher J. Anker, H. Thakrar, Naomi Horiba, Ajay Kumar Dubey, Joel S. Greenberger, Adam Raben, Jeffrey K. Giguere, Kevin S. Roof, Gregory M.M. Videtic, Jondavid Pollock, Howard Safran, Christopher H. Crane - JAMA Oncology 2017 cited by 208

  23. Relationships Among Body Mass Index, Longitudinal Body Composition Alterations, and Survival in Patients With Locally Advanced Pancreatic Cancer Receiving Chemoradiation: A Pilot Study

    Authors: Shalini Dalal, David Hui, Luc Bidaut, Kristen E. Lem, Egidio Del Fabbro, Christopher H. Crane, Cielito C. Reyes‐Gibby, Deepak G. Bedi, Éduardo Bruera - Journal of Pain and Symptom Management 2012 cited by 190

  24. NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).

    Authors: Laura A. Dawson, Kathryn Winter, Jennifer J. Knox, Andrew X. Zhu, Sunil Krishnan, Chandan Guha, Lisa A. Kachnic, Michael T. Gillin, Theodore S. Hong, T. Craig, Ali Hosni, Eric Xueyu Chen, Anne M. Noonan, Eugene J. Koay, Rishi Sinha, Michael Lock, Nitin Ohri, Jennifer A. Dorth, Jennifer Moughan, Christopher H. Crane - Journal of Clinical Oncology 2023 cited by 60